CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
8 results
Search Results
Now showing 1 - 8 of 8
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Instrumentos para medir la capacidad funcional intrínseca y la fragilidad de personas mayores en la Atención Primaria en Chile(2022); Scopus© Citations 3 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 1Scopus© Citations 3 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, How to Do an Electrophysiological Study of Myoclonus(2022); 1Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma(2022); Susan Lightman<jats:title>Abstract</jats:title><jats:sec> <jats:title>Objectives</jats:title> <jats:p>To report patients with systemic lymphoma and cytomegalovirus (CMV) retinitis, treated with a combination of oral and intravitreal antiviral agents on an outpatient basis.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Retrospective cases series. Information was gathered from the database of the Uveitis clinics at Moorfields Eye Hospital, United Kingdom from December 2014 to December 2018. The inclusion criteria comprised the diagnosis of systemic lymphoma, associated with a diagnosis of CMV retinitis. Exclusion criteria were alternative ocular diagnosis, human immunodeficiency virus (HIV), primary intraocular lymphoma, or other causes of immunosuppression.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>All seven subjects had been under oncologist care for systemic lymphoma. CMV retinitis presented with a median of 61 months after the systemic lymphoma diagnosis. Five patients underwent a vitreous biopsy, and four of them returned PCR positive for CMV and the fifth patient had PCR positive in a blood sample. All patients were treated with oral Valganciclovir, with an induction dose of 900 mg every 12 h for up to 3 weeks until disease resolution and a maintenance dose thereafter. All but one received additional intravitreal Foscarnet injections, with a dose of 2.4 mg /0.1 ml.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>The management of patients with systemic lymphoma and CMV retinitis with oral and intravitreal antiviral agents, resulted in effective disease control.</jats:p> </jats:sec>1Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Varus mechanism is associated with high incidence of popliteal artery lesions in multiligament knee injuries(2020)6Scopus© Citations 13 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A proposal for new diagnostic criteria for ALS(2020)Scopus© Citations 405 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Determination of Brain Death/Death by Neurologic Criteria(2020)Scopus© Citations 328 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparison of transperineal ultrasound with POP-Q for assessing symptoms of prolapse(2019)4Scopus© Citations 20